Somewhat Positive News Coverage Somewhat Unlikely to Impact Cantel Medical (CMD) Share Price

Media headlines about Cantel Medical (NYSE:CMD) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cantel Medical earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.0031544183271 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

CMD stock opened at $111.41 on Friday. The firm has a market cap of $4,647.36, a PE ratio of 53.56 and a beta of 1.18. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.58 and a quick ratio of 1.57. Cantel Medical has a 52 week low of $69.21 and a 52 week high of $123.60.

How to Become a New Pot Stock Millionaire

ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Cantel Medical (CMD) Share Price” was first published by WKRB News and is the property of of WKRB News. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at

Cantel Medical Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Insider Buying and Selling by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with's FREE daily email newsletter.

Leave a Reply